Haemonetics Corporation (HAE) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $91.34 --0%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Haemonetics Corporation (NYSE: HAE) reported Q3 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $231.8 million versus the consensus estimate of $234.85 million.
For earnings history and earnings-related data on Haemonetics Corporation (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- BK Technologies (BKTI) Tops Q2 EPS by 11c
- Bragg Gaming Group Inc. (BRAG) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
